ENDOSPAN RECEIVES ADDITIONAL $25M FROM ARTIVION FOR NEXUS FDA APPROVAL PATH

HERZELIA, Israel, July 2, 2024 /PRNewswire/ — Endospan Ltd (“Endospan”), an Israeli-based, privately-held developer of the NEXUS® Stent Graft System (“NEXUS”), announced today an agreement with Artivion, Inc (“Artivion”) for additional loans of up to $25M for U.S. Food and Drug…